Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |